Crossmark

Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model

Crossref DOI link: https://doi.org/10.1186/s40035-021-00235-4

Published Online: 2021-03-31

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Ju

Hu, Hui-Jie

Liu, Zi-Kai

Liu, Jing-Jing

Wang, Shan-Shan

Cheng, Qing

Chen, Hong-Zhuan

Song, Mingke http://orcid.org/0000-0002-8056-0328
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81671375, 91949116, 81873807)

Innovative Research Team of High-level Local Universities in Shanghai, China
License Information

Text and Data Mining valid from 2021-03-31

Version of Record valid from 2021-03-31
More Information

Article History

Received: 23 September 2020

Accepted: 9 March 2021

First Online: 31 March 2021

Declarations

:

: Animal experimental procedures were approved by the Animal Experimentation Ethics Committee and Institutional Animal Care and Use Committee (IACUC) at Shanghai Jiao Tong University School of Medicine.

: All authors read and approved the final manuscript.

: The authors declare that there is no conflict of interest in this article.

Document is current

Any future updates will be listed below